Christian Schröer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christian Schröer has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Joost C. M. Holthuis
Molecular Cell Biology Division, Department of Biology and Chemistry, University of Osnabrück, Osnabrück, Germany
5 shared publications - Matthijs Kol
Division of Molecular Cell Biology, Department of Biology/Chemistry, Osnabrück University, Osnabrück, Germany; Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
3 shared publications Angelika Hilderink
Molecular Cell Biology Section, Department of Biology/Chemistry, Osnabrück University, Osnabrück, Germany
2 shared publications- Ann-Katrin Lehmann
Molecular Cell Biology Section, Department of Biology/Chemistry, Osnabrück University, Osnabrück, Germany
2 shared publications Britta Fiedler
Molecular Cell Biology Section, Department of Biology/Chemistry, Osnabrück University, Osnabrück, Germany
2 shared publications- Dirk Trauner
Department of Chemistry University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach, we here identified the bridge-like lipid transport protein VPS13C/PARK23 as a key component of a global early response pathway to lysosome damage. VPS13C readily binds lysosomes under mechanical or osmotic tension in anticipation of membrane lesions. The latter trigger a conformational change in the protein’s C -terminus, involving its ATG2C domain acting as sensor of damage-induced lipid packing defects. We show that ER-lysosome contacts formed by VPS13C provide critical binding platforms for OSBP/ORPs to enable efficient ER wrapping of damaged lysosomes. A chemical approach to assess directional ER-to-lysosome lipid transport revealed that VPS13C is essential for large-scale lipid delivery to acutely damaged lysosomes to facilitate their repair. Our findings offer new mechanistic insights into how loss-of-function mutations in VPS13C may enhance the risk of Parkinson’s disease.
- 2 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessVPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach, we here identified the bridge-like lipid transport protein VPS13C/PARK23 as a key component of a global early response pathway to lysosome damage. VPS13C readily binds lysosomes under mechanical or osmotic tension in anticipation of membrane lesions. The latter trigger a conformational change in the protein’s C -terminus, involving its ATG2C domain acting as sensor of damage-induced lipid packing defects. We show that ER-lysosome contacts formed by VPS13C provide critical binding platforms for OSBP/ORPs to enable efficient ER wrapping of damaged lysosomes. A chemical approach to assess directional ER-to-lysosome lipid transport revealed that VPS13C is essential for large-scale lipid delivery to acutely damaged lysosomes to facilitate their repair. Our findings offer new mechanistic insights into how loss-of-function mutations in VPS13C may enhance the risk of Parkinson’s disease.
- Open Access
VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach, we here identified the bridge-like lipid transport protein VPS13C/PARK23 as a key component of a global early response pathway to lysosome damage. VPS13C readily binds lysosomes under mechanical or osmotic tension in anticipation of membrane lesions. The latter trigger a conformational change in the protein’s C -terminus, involving its ATG2C domain acting as sensor of damage-induced lipid packing defects. We show that ER-lysosome contacts formed by VPS13C provide critical binding platforms for OSBP/ORPs to enable efficient ER wrapping of damaged lysosomes. A chemical approach to assess directional ER-to-lysosome lipid transport revealed that VPS13C is essential for large-scale lipid delivery to acutely damaged lysosomes to facilitate their repair. Our findings offer new mechanistic insights into how loss-of-function mutations in VPS13C may enhance the risk of Parkinson’s disease.
Open AccessVPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach, we here identified the bridge-like lipid transport protein VPS13C/PARK23 as a key component of a global early response pathway to lysosome damage. VPS13C readily binds lysosomes under mechanical or osmotic tension in anticipation of membrane lesions. The latter trigger a conformational change in the protein’s C -terminus, involving its ATG2C domain acting as sensor of damage-induced lipid packing defects. We show that ER-lysosome contacts formed by VPS13C provide critical binding platforms for OSBP/ORPs to enable efficient ER wrapping of damaged lysosomes. A chemical approach to assess directional ER-to-lysosome lipid transport revealed that VPS13C is essential for large-scale lipid delivery to acutely damaged lysosomes to facilitate their repair. Our findings offer new mechanistic insights into how loss-of-function mutations in VPS13C may enhance the risk of Parkinson’s disease.
- Open Access
- 19 September 2025
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (11) , 100907
Mitochondria-specific photorelease of ceramide induces apoptosis
- 19 September 2025
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (11) , 100907
Open AccessMitochondria-specific photorelease of ceramide induces apoptosis
- Open Access
- 11 December 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (1) , 100724
Optical control of sphingolipid biosynthesis using photoswitchable sphingosines
- 11 December 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (1) , 100724
Open AccessOptical control of sphingolipid biosynthesis using photoswitchable sphingosines
- Open Access
Optical control of sphingolipid biosynthesis using photoswitchable sphingosines
Sphingolipid metabolism comprises a complex interconnected web of enzymes, metabolites and modes of regulation that influence a wide range of cellular and physiological processes. Deciphering the biological relevance of this network is challenging as numerous intermediates of sphingolipid metabolism are short-lived molecules with often opposing biological activities. Here, we introduce clickable, azobenzene-containing sphingosines, termed caSph s, as light-sensitive substrates for sphingolipid biosynthesis. Photo-isomerization of the azobenzene moiety enables reversible switching between a straight trans - and curved cis -form of the lipid’s hydrocarbon tail. Combining in vitro enzyme assays with metabolic labeling studies, we demonstrate that trans -to- cis isomerization of caSph s profoundly stimulates their metabolic conversion by ceramide synthases and downstream sphingomyelin synthases. These light-induced changes in sphingolipid production rates are acute, reversible, and can be implemented with great efficiency in living cells. Our findings establish caSph s as versatile tools with unprecedented opportunities to manipulate sphingolipid biosynthesis and function with the spatiotemporal precision of light.
Open AccessOptical control of sphingolipid biosynthesis using photoswitchable sphingosines
Sphingolipid metabolism comprises a complex interconnected web of enzymes, metabolites and modes of regulation that influence a wide range of cellular and physiological processes. Deciphering the biological relevance of this network is challenging as numerous intermediates of sphingolipid metabolism are short-lived molecules with often opposing biological activities. Here, we introduce clickable, azobenzene-containing sphingosines, termed caSph s, as light-sensitive substrates for sphingolipid biosynthesis. Photo-isomerization of the azobenzene moiety enables reversible switching between a straight trans - and curved cis -form of the lipid’s hydrocarbon tail. Combining in vitro enzyme assays with metabolic labeling studies, we demonstrate that trans -to- cis isomerization of caSph s profoundly stimulates their metabolic conversion by ceramide synthases and downstream sphingomyelin synthases. These light-induced changes in sphingolipid production rates are acute, reversible, and can be implemented with great efficiency in living cells. Our findings establish caSph s as versatile tools with unprecedented opportunities to manipulate sphingolipid biosynthesis and function with the spatiotemporal precision of light.